Likewise, the evaluation of genes such as ALK, ROS1, RET, and HER2 is crucial in assessing non-small-cell lung cancer (NSCLC), as established in the National Comprehensive Cancer Network (NCCN) guidelines [7]. Here, ROS1 is linked to non-small cell lung carcinoma.